Principal/Lead Biostatistician

Job Location
200 Cardinal Way
Redwood City, CA 94063
Job Description


The Principal/Lead Biostatistician provides statistical expertise and leadership to clinical projects. As the statistical program lead, the Principal/Lead Biostatistician partners with key internal and external stakeholders to develop overall program strategy and design, analyze, and interpret clinical development and validation studies in support of GRAIL products.



  • Provides strategic input for and is a key contributor to GRAIL product development.
  • Represents Biostatistics function and collaborates with internal and external thought leaders in the design, analysis, interpretation, and publication of clinical studies.
  • Contributes to protocols, statistical analysis plans, study reports, presentations, and publications of clinical studies.
  • Partners with leading clinicians and computational scientists to develop algorithms for cancer detection.   
  • Works on significant and unique issues that require exercising independent judgment and developing/adapting methodology.
  • Stays abreast of industry and academic developments in the Statistical Genomics field and applies to clinical study design and analysis.


  • 10+ years of experience in academia or industry. Molecular diagnostics industry experience preferred.
  • PhD in Biostatistics or equivalent.
  • Strong knowledge of theoretical and applied statistics
  • Outstanding verbal, writing, and presentation skills with a strong ability to influence and communicate effectively throughout all levels of the organization and externally.
  • Demonstrated success leading the statistical portion of a clinical development program in industry.
  • Knowledge of applicable regulatory rules and guidelines, e.g., ICH, GCP, HIPAA.
  • Experience programing in SAS or R.
  • Strong team player with demonstrated track record of success in cross­-functional team environment. 
About Our Organization

GRAIL, Inc. is developing paradigm­-changing clinical assays for early cancer detection, based on unique biological insights from high-­intensity sequencing analysis of circulating cell­-free nucleic acids. We are seeking passionate and talented individuals to join us in realizing our mission, which has the potential to dramatically reduce the global burden of cancer.

A research duo finds that science and technology graduate students who turn away from academic careers do so because of changes in their own interests.

Students whose classmates are interested in science are more likely to think about a career in science, technology, engineering, and mathematics, a new study says.

CNBC reports that the genetic counseling field is expected to grow as personalized medicine becomes more common.

Gladys Kong writes at Fortune that her STEM background has helped her as a CEO.